ASLAN Pharmaceuticals Announces Expansion Of Its Collaboration With Zenyaku To Investigate The Biology Underlying Differential Effects Of Eblasakimab Compared To Other Biologics
New research collaboration will explore the differentiation of eblasakimab's mechanism of action versus biologic therapies for atopic dermatitis (AD), dupilumab and lebrikizumab.The findings will deepen understanding of